According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...

This study is a major step toward the ultimate goal of treating fragile X syndrome (FXS), an inherited form of mental retardation and the predominant monogenetic cause of autism. The study is also ...

A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...

The FREE methylation test has been closely related to FMR1 protein expression and identified fragile X syndrome (FXS)-affected males and females with 100% specificity in our small study (75 male ...

What is Fragile X syndrome? “Fragile X Syndrome (FXS) is the most common inherited cause of learning disability,” says ...

US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating Fragile X syndrome (FXS), a genetic disorder linked to autism and ...

The drug is also being evaluated for Fragile X syndrome (FXS), the leading cause of inherited intellectual disabilities, 3 in a pivotal Phase 2b/3 program in the U.S. Jordan’s Guardian Angels ...